Kiadis Pharma N.V. | Ownership
Companies that own Kiadis Pharma N.V.
BNP Paribas Asset Management Belgium SA
119,740
0.6%
0
0.01%
07/31/2018
GO ETF Solutions LLP
74,150
0.37%
74,150
0.04%
02/28/2018
CAPFI DELEN Asset Management SA
62,679
0.31%
62,679
0%
06/29/2018
FundQuest Advisor
41,691
0.21%
0
0.12%
07/31/2018
Rhenman & Partners Asset Management AB
36,135
0.18%
36,135
0.03%
12/31/2017
Quaestor Vermogensbeheer NV
21,620
0.11%
21,620
0.09%
06/30/2017
Handelsbanken Fonder AB
9
0%
-89,991
0%
08/31/2018
KBC Asset Management NV
0
0%
-31,648
0%
12/31/2017
Aviva Investors Global Services Ltd.
0
0%
-88,147
0%
10/15/2017
| Address |
Paasheuvelweg 25
Amsterdam Noord-Holland 1105 BP
Netherlands
|
|
Employees
|
- |
| Website |
http://www.kiadis.com |
| Updated |
07/08/2019 |
| Kiadis Pharma NV is a clinical stage biopharmaceutical company. It engages in the research, development, and future commercialization of cell-based immunotherapy products for treatment of blood cancers and inherited blood disorders. The company provide the products for Allodepleted T-cell ImmunotheRapeutics that are based on its theralux platform. |
